Selected recent publications:

• Luketich JD, Nason KS, Keeley S, Awais O, Shende M, Schuchert MJ, Abbas G, Jobe BA, Landreneau RJ, Pennathur A. “Outcomes after a Decade of Laparoscopic Giant Paraesophageal Hernia Repair.” J Thorac Cardiovasc Surg. Feb 2010; 139(2):395-404, 404.e1
• Murphy T, Jobe BA. “Endoluminal Management of Anastomotic Dehiscence After Esophagectomy: An Increasing Quiver of Options Reflects the Difficulty in Realizing a Definitive Therapy.” Gastrointest Endosc. Feb 2010; 71(2):387-9
• McMahon BP, Jobe BA, Pandolfino JE, Gregersen H.  “Do we really understand the role of the oesophagogastric junction in disease?”  World J Gastroenterol. 2009 Jan 14;15(2):144-50.
• Gilbert S, Jobe BA. “Surgical therapy for Barrett’s esophagus with high-grade dysplasia and early esophageal carcinoma.”  Surg Oncol Clin N Am. 2009 Jul;18(3):523-31.
• O’Rourke RW, Diggs BS, Schipper P, Schindler JS, Morris C, Kim C, Witteman BP, Luketich JD, Jobe BA.  “Proton pump inhibitor therapy in patients with symptoms of laryngopharyngeal reflux:  A symptom specific analysis of response to treatment in an unselected population.”  Surg Endosc. (under review)
• Shaheen NJ, Sharma P, Overholt BF, Lightdale CJ, Wolfsen HC, Sampliner RE, Wang KK, Bronner MP, Goldblum JR, Jobe BA, Eisen GM, Fleischer DE, Sharma VK, Hoffman B, Rothstein RI, Mashimo H, Chang KJ, Muthusamy VR, Edmundowicz SA, Spechler SJ, Siddiqui A, Infantolino A, Falk GW, Kimmer MB, Chak A.  “Radiofrequency Ablation (RFA) in Barrett’s Esophagus with Dysplasia: Interim Results of the AIM Dysplasia Trial.” N Engl J Med.2009 May 28;360(22):2277-88.
• O'Rourke RW, Metcalf MD, White AE, Madala A, Winters BR, Maizlin II, Jobe BA, Roberts CT Jr, Slifka MK, Marks DL.  “Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue.”  Int J Obese (Lond). 2009 Sep;33(9):978-90.
• Witteman BPL, Foxwell TJ, Monsheimer S, Gelrud A, Eid GM, Nieponice A, O’Rourke RW, Hoppo T, Bouvy ND, Badylak SF, Jobe BA.  “Transoral endoscopic inner layer esophagectomy:  Management of high grade dysplasia and superficial cancer with organ preservation.” J Gastrointest Surg. Dec 2009; 13(12):2104-12.
• Perry KA. Enestvedt CK. Pham T. Welker M. Jobe BA. Hunter JG. Sheppard BC. “Comparison of Laparoscopic Inversion Esophagectomy and open Transhiatal Esophagectomy for High Grade Dysplasia and Stage I Esophageal Adenocarcinoma.” Archives of Surgery. Jul 2009; 144(7):679-84.
• Enestvedt CK, Kim C, McConnell PW, Diggs BS, Vernon A, O’Rourke RW, Luketich JD, Jobe BA.  “Trends in the management of esophageal carcinoma based on provider volume: Treatment practices of 618 esophageal surgeons.” Dis Esophagus.  Jun 2009; [Epub ahead of print]

CONTACT INFORMATION

Blair A. Jobe, MD
Phone: (412) 623-2025
Email:jobeba@upmc.edu